Literature DB >> 33191760

Aortic Distensibility Can Predict Events in Patients With Premature Coronary Artery Disease: A Cardiac Magnetic Resonance Study.

Nady A Razik1, Y T Kishk1, Mohammed Essa1, Mohamed Abdel Ghany1.   

Abstract

Noninvasive assessment of aortic distensibility (AD) is feasible with cardiac magnetic resonance (CMR). We investigated the relationship between AD (assessed by CMR) and coronary artery disease (CAD) severity (assessed by the SYNTAX score) in patients with premature CAD. We recruited 125 patients with CAD confirmed by coronary angiography (males were <55 years old and females <65 years old). We excluded patients with significant aortic disease or contraindications to CMR. We also recruited 25 age- and sex-matched healthy patients as controls. One-year follow-up was also carried out. Aortic distensibility at the aortic root (AR) and descending aorta (DA) was significantly (P < .001 for both) lower in the patient group. There was a significant negative correlation between SYNTAX score and AD at the AR (r = -0.56; P < .001) and DA (r = -0.34; P < .001), but insignificant correlation with distensibility at the ascending aorta (AA; r = -0.03; P = .81). AR, AA, and DA distensibility, as well as left ventricular ejection fraction were predictors of adverse events. The severity of CAD in young patients is associated with decreased AD, especially at the level of the AR. Aortic distensibility can predict adverse events in these patients.

Entities:  

Keywords:  SYNTAX score; aortic distensibility; arteriosclerosis; cardiac magnetic resonance; premature coronary artery disease

Year:  2020        PMID: 33191760     DOI: 10.1177/0003319720968391

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  Aortic Stiffness by Cardiac Magnetic Resonance: Prognostic tool or Bystander?

Authors:  Sérgio Figueiredo Câmara; Henrique Barbosa Ribeiro
Journal:  Arq Bras Cardiol       Date:  2022-05       Impact factor: 2.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.